| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.26B | +0.2% | +8.6% |
| Cost of Revenue | $2.25B | +0.6% | +7.1% |
| Gross Profit | $8.00B | +0.1% | +9.1% |
| R&D Expense | $1.43B | -3.2% | +5.7% |
| SG&A Expense | $667.0M | -9.1% | -6.2% |
| Operating Income | $2.19B | -6.2% | +15.6% |
| Interest Expense | $67.0M | +0.0% | +0.0% |
| Pre-tax Income | $2.51B | +4.4% | +43.9% |
| Income Tax | $426.0M | -17.9% | +94.5% |
| Net Income | $2.09B | +10.5% | +36.6% |
| EPS (Basic) | $2.20 | +11.7% | +37.5% |
| EPS (Diluted) | $2.19 | +11.7% | +38.6% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.98B | -13.4% | +12.3% |
| Accounts Receivable | $5.47B | -2.2% | +15.5% |
| Current Assets | $21.06B | -16.8% | -1.7% |
| Total Assets | $95.14B | -2.5% | +4.1% |
| Current Liabilities | $21.41B | -5.0% | +10.5% |
| Long-term Debt | $8.44B |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.32B | +213.0% | +16.8% |
| Capital Expenditures | $139.0M | +3.0% | -31.9% |
| Investing Cash Flow | $519.0M | -55.5% | +339.2% |
| Financing Cash Flow | -$4.24B | -69.6% | -193.5% |
| Free Cash Flow | $2.18B | +259.8% | +22.4% |
| +0.1% |
| Total Liabilities | $35.12B | -3.1% | +6.9% |
| Stockholders' Equity | $60.02B | -2.1% | +2.6% |